A detailed history of Bessemer Group Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bessemer Group Inc holds 9,805 shares of PRCT stock, worth $720,275. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,805
Previous 17,705 44.62%
Holding current value
$720,275
Previous $1.08 Million 27.29%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$56.31 - $84.99 $444,849 - $671,421
-7,900 Reduced 44.62%
9,805 $786,000
Q2 2024

Aug 13, 2024

SELL
$45.73 - $69.19 $151,823 - $229,710
-3,320 Reduced 15.79%
17,705 $1.08 Million
Q1 2024

May 13, 2024

BUY
$40.38 - $50.75 $6,057 - $7,612
150 Added 0.72%
21,025 $1.04 Million
Q4 2023

Feb 09, 2024

BUY
$24.89 - $43.41 $128,432 - $223,995
5,160 Added 32.83%
20,875 $874,000
Q3 2023

Nov 13, 2023

BUY
$30.02 - $38.81 $471,764 - $609,899
15,715 New
15,715 $516,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.28B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.